GNRH1 and endometriosis: Some newer therapeutics such as GnRH antagonists are often marketed as ‘new’ and innovative, but they use the same pharmacokinetic mechanism of hypoestrogenism as all endocrine endometriosis drugs (Vercellini et al., 2019).